Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's disease by etanercept treatment. (2019)

First Author: Pido-Lopez J
Attributed to:  Targeting the innate immune system in Huntington's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-43627-3

PubMed Identifier: 31076648

Publication URI: http://europepmc.org/abstract/MED/31076648

Type: Journal Article/Review

Volume: 9

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322